Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry, ENSG00000229447, encodes the general transcription factor IIA, 2, 12kDa (GTF2A2) pseudogene. Pseudogenes are genomic sequences similar to normal genes but are non-functional; they do not produce active proteins and typically lack regulatory or coding potential. As such, ENSG00000229447 does not serve as a drug target or have known roles in disease, cellular processes, or clinical pharmacology[1][3]. Summary: ENSG00000229447 is a pseudogene related to the GTF2A2 transcription factor. It is not a true protein-coding gene, is not considered a molecular or therapeutic target, and lacks biological or pharmacological significance[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on General transcription factor IIA, 2, 12kDa pseudogene.